Lansoprazole
- Product NDC
- 72603-314
- 11-digit product format
- 726030314
- Labeler code
- 72603
- Product ID
- 72603-314_ac051296-6fe3-4ab5-a001-cc3e06199a22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- Route
- ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA207167
- Marketing category
- ANDA
- Marketing start
- 2023-03-28
- Substance
- LANSOPRAZOLE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0K5C5T2QPG | LANSOPRAZOLE | 103577-45-3 | LANSOPRAZOLE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-314-10 | 72603031410 | 10 BLISTER PACK in 1 CARTON (72603-314-10) / 10 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK (72603-314-01) | 10 blister pack | 2023-03-28 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Lansoprazole | NorthStar Rx LLC | Aurobindo Pharma Limited | 2024-08-08 | Human Prescription Drug Label | 1 |